NeueHealth (NEUE) Competitors $6.73 +0.01 (+0.16%) Closing price 03:58 PM EasternExtended Trading$6.72 -0.01 (-0.09%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEUE vs. KINS, HIT, GOCO, RDZN, AAME, ZBAO, HUIZ, AIFU, OXBR, and FGNXShould you be buying NeueHealth stock or one of its competitors? The main competitors of NeueHealth include Kingstone Companies (KINS), Health In Tech (HIT), GoHealth (GOCO), Roadzen (RDZN), Atlantic American (AAME), Zhibao Technology (ZBAO), Huize (HUIZ), AIFU (AIFU), Oxbridge Re (OXBR), and Fundamental Global (FGNX). These companies are all part of the "insurance" industry. NeueHealth vs. Its Competitors Kingstone Companies Health In Tech GoHealth Roadzen Atlantic American Zhibao Technology Huize AIFU Oxbridge Re Fundamental Global NeueHealth (NYSE:NEUE) and Kingstone Companies (NASDAQ:KINS) are both small-cap insurance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings. Does the media prefer NEUE or KINS? In the previous week, NeueHealth and NeueHealth both had 1 articles in the media. Kingstone Companies' average media sentiment score of 0.95 beat NeueHealth's score of -1.00 indicating that Kingstone Companies is being referred to more favorably in the news media. Company Overall Sentiment NeueHealth Negative Kingstone Companies Positive Do analysts recommend NEUE or KINS? NeueHealth presently has a consensus target price of $7.00, indicating a potential upside of 4.00%. Given NeueHealth's stronger consensus rating and higher probable upside, analysts plainly believe NeueHealth is more favorable than Kingstone Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeueHealth 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Kingstone Companies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is NEUE or KINS more profitable? Kingstone Companies has a net margin of 14.84% compared to NeueHealth's net margin of -9.08%. Kingstone Companies' return on equity of 33.21% beat NeueHealth's return on equity.Company Net Margins Return on Equity Return on Assets NeueHealth-9.08% N/A -13.01% Kingstone Companies 14.84%33.21%6.72% Which has stronger valuation & earnings, NEUE or KINS? Kingstone Companies has lower revenue, but higher earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than Kingstone Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeueHealth$936.66M0.06-$134.68M-$15.97-0.42Kingstone Companies$155.14M1.24$18.36M$2.006.81 Do institutionals & insiders have more ownership in NEUE or KINS? 63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 14.9% of Kingstone Companies shares are owned by institutional investors. 63.3% of NeueHealth shares are owned by insiders. Comparatively, 5.1% of Kingstone Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, NEUE or KINS? NeueHealth has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Comparatively, Kingstone Companies has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. SummaryKingstone Companies beats NeueHealth on 8 of the 14 factors compared between the two stocks. Get NeueHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEUE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEUE vs. The Competition Export to ExcelMetricNeueHealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$60.64M$7.50B$5.73B$21.51BDividend YieldN/A2.86%5.90%3.50%P/E Ratio-0.4274.3075.8629.83Price / Sales0.0636.41528.7453.44Price / CashN/A24.1937.1724.76Price / Book-0.047.2012.794.53Net Income-$134.68M$241.92M$3.28B$998.53M7 Day Performance-0.36%0.59%0.22%1.07%1 Month Performance2.61%3.32%4.61%4.41%1 Year Performance31.21%2.55%68.33%14.45% NeueHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEUENeueHealth0.879 of 5 stars$6.73+0.2%$7.00+4.0%+28.2%$60.64M$936.66M-0.421,252News CoverageNegative NewsShort Interest ↑KINSKingstone Companies1.7299 of 5 stars$13.21-1.1%N/A+47.9%$188.92M$155.14M6.6190Positive NewsHITHealth In TechN/A$2.83+4.4%$2.50-11.7%N/A$159.58M$26.69M0.0079GOCOGoHealth2.7162 of 5 stars$4.79+1.1%$12.00+150.5%-45.5%$135.61M$798.89M-1.332,261Positive NewsRDZNRoadzen2.3237 of 5 stars$0.99+5.2%$5.00+406.4%-33.6%$71.34M$44.30M-0.65324News CoveragePositive NewsAAMEAtlantic American2.2096 of 5 stars$3.26+1.2%N/A+102.4%$65.68M$188.23M32.60140Positive NewsGap DownZBAOZhibao TechnologyN/A$1.09+4.8%N/A-72.0%$32.78M$25.27M0.00148Gap DownHigh Trading VolumeHUIZHuize1.3355 of 5 stars$2.68+0.4%$2.30-14.2%-80.1%$26.94M$171.10M-6.381,640Earnings ReportShort Interest ↑Gap DownAIFUAIFU1.2086 of 5 stars$6.17-4.6%N/AN/A$18.73M$247.81M8.454,707Upcoming EarningsAnalyst DowngradeOXBROxbridge Re2.688 of 5 stars$2.27flat$5.00+120.3%+17.5%$17.11M$1.98M-5.543Positive NewsShort Interest ↓FGNXFundamental Global0.5379 of 5 stars$7.46+7.3%N/AN/A$9.23M$17.35M0.009News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies Kingstone Companies Alternatives Health In Tech Alternatives GoHealth Alternatives Roadzen Alternatives Atlantic American Alternatives Zhibao Technology Alternatives Huize Alternatives AIFU Alternatives Oxbridge Re Alternatives Fundamental Global Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NEUE) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeueHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.